Clinical Trial Update: Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pitavastatin pre-treatment in patients undergoing elective percutaneous coronary intervention for stable angina pectoris has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina Pectoris

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Percutaneous Coronary Intervention | Phase 4 | Status: WITHDRAWN